PT-2.0

N/A

Report date: 2026/03/13 20:02:36
NME

Base Information

Drug NamePT-2.0
Drug Alias NameSASP programmeResearch programme: antibacterial protein-based therapeutics - Phico TherapeuticsPT-3.33PT-2.0PT-3 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA modulators
TargetsDNA
Therapy Area/IndicationsPseudomonas InfectionsEscherichia coli InfectionsGram-Negative Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPhico Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesPhico Therapeutics
Inactive CompaniesN/A
Active IndicationsPseudomonas InfectionsEscherichia coli InfectionsGram-Negative Bacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A